1. Home
  2. UVSP vs COLL Comparison

UVSP vs COLL Comparison

Compare UVSP & COLL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • UVSP
  • COLL
  • Stock Information
  • Founded
  • UVSP 1876
  • COLL 2002
  • Country
  • UVSP United States
  • COLL United States
  • Employees
  • UVSP N/A
  • COLL N/A
  • Industry
  • UVSP Major Banks
  • COLL Biotechnology: Pharmaceutical Preparations
  • Sector
  • UVSP Finance
  • COLL Health Care
  • Exchange
  • UVSP Nasdaq
  • COLL Nasdaq
  • Market Cap
  • UVSP 881.8M
  • COLL 947.6M
  • IPO Year
  • UVSP 1989
  • COLL 2015
  • Fundamental
  • Price
  • UVSP $29.40
  • COLL $29.23
  • Analyst Decision
  • UVSP Hold
  • COLL Strong Buy
  • Analyst Count
  • UVSP 3
  • COLL 5
  • Target Price
  • UVSP $29.00
  • COLL $43.80
  • AVG Volume (30 Days)
  • UVSP 106.2K
  • COLL 297.6K
  • Earning Date
  • UVSP 07-23-2025
  • COLL 05-08-2025
  • Dividend Yield
  • UVSP 3.04%
  • COLL N/A
  • EPS Growth
  • UVSP 11.32
  • COLL N/A
  • EPS
  • UVSP 2.66
  • COLL 1.25
  • Revenue
  • UVSP $294,306,000.00
  • COLL $664,283,000.00
  • Revenue This Year
  • UVSP $11.24
  • COLL $20.00
  • Revenue Next Year
  • UVSP $4.30
  • COLL $3.74
  • P/E Ratio
  • UVSP $10.96
  • COLL $23.30
  • Revenue Growth
  • UVSP 2.88
  • COLL 17.17
  • 52 Week Low
  • UVSP $20.37
  • COLL $23.23
  • 52 Week High
  • UVSP $32.75
  • COLL $42.29
  • Technical
  • Relative Strength Index (RSI)
  • UVSP 47.15
  • COLL 54.21
  • Support Level
  • UVSP $28.84
  • COLL $28.74
  • Resistance Level
  • UVSP $30.68
  • COLL $29.50
  • Average True Range (ATR)
  • UVSP 0.75
  • COLL 0.77
  • MACD
  • UVSP -0.21
  • COLL -0.04
  • Stochastic Oscillator
  • UVSP 26.84
  • COLL 40.67

About UVSP Univest Financial Corporation

Univest Financial Corp is engaged in domestic banking services for individuals, businesses, municipalities and non-profit organizations. The bank has three operating segments; Banking segment provides financial services including a full range of banking services such as deposit taking, loan origination, and servicing, mortgage banking, other general banking services, and equipment lease financing, Wealth Management segment offers investment advisory, financial planning, trust and brokerage services, and The Insurance segment includes a full-service insurance brokerage agency offering commercial property and casualty insurance, employee benefits solutions, personal insurance lines and human resources consulting. It generates majority of its revenue from the banking segment.

About COLL Collegium Pharmaceutical Inc.

Collegium Pharmaceutical Inc is a specialty pharmaceutical company. The company is engaged in developing and planning to commercialize abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. The DETERx platform technology is designed to maintain the extended-release and safety profiles of abused drugs in the face of various methods including chewing, crushing, and dissolving. Its product portfolio includes Jornay, Xtampza ER, which is an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta Products, which are extended-release and immediate-release formulations of tapentadol; Belbuca, and Symproic.

Share on Social Networks: